INTERNATIONAL PATENT: VIMELA THERAPEUTICS, INC. FILES APPLICATION FOR "TOPICAL DELIVERY OF MELANOCORTIN-1 RECEPTOR AGONISTS FORMULATIONS"

GENEVA, Dec. 16 -- VIMELA THERAPEUTICS, INC. (The Cambridge Partnership, Dorothy Hodgkin Bldg.Babraham Research CampusCambridge Cambridgeshire CB22 3FH) filed a patent application (PCT/IB2025/055844) for "TOPICAL DELIVERY OF MELANOCORTIN-1 RECEPTOR AGONISTS FORMULATIONS" on Jun 06, 2025. With publication no. WO/2025/253347, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BOUIX-PETER, Claire (c/o Vimela Therapeutics, Inc.The Cambridge Partnership, Dorothy Hodgkin Bldg.Babraham Research CampusCambridge CB22 3FH), DEAN, Yann...